Damaraju CV

References (3)

Title : The cognitive benefits of galantamine are sustained for at least 36 months: a long-term extension trial - Raskind_2004_Arch.Neurol_61_252
Author(s) : Raskind MA , Peskind ER , Truyen L , Kershaw P , Damaraju CV
Ref : Archives of Neurology , 61 :252 , 2004
Abstract : Raskind_2004_Arch.Neurol_61_252
ESTHER : Raskind_2004_Arch.Neurol_61_252
PubMedSearch : Raskind_2004_Arch.Neurol_61_252
PubMedID: 14967774

Title : An open-label extension trial of galantamine in patients with probable vascular dementia and mixed dementia - Erkinjuntti_2003_Clin.Ther_25_1765
Author(s) : Erkinjuntti T , Kurz A , Small GW , Bullock R , Lilienfeld S , Damaraju CV
Ref : Clin Ther , 25 :1765 , 2003
Abstract : Erkinjuntti_2003_Clin.Ther_25_1765
ESTHER : Erkinjuntti_2003_Clin.Ther_25_1765
PubMedSearch : Erkinjuntti_2003_Clin.Ther_25_1765
PubMedID: 12860497

Title : Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial - Erkinjuntti_2002_Lancet_359_1283
Author(s) : Erkinjuntti T , Kurz A , Gauthier S , Bullock R , Lilienfeld S , Damaraju CV
Ref : Lancet , 359 :1283 , 2002
Abstract : Erkinjuntti_2002_Lancet_359_1283
ESTHER : Erkinjuntti_2002_Lancet_359_1283
PubMedSearch : Erkinjuntti_2002_Lancet_359_1283
PubMedID: 11965273